These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35935934)

  • 1. The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis.
    Dilaghi E; Bellisario M; Esposito G; Carabotti M; Annibale B; Lahner E
    Front Immunol; 2022; 13():910077. PubMed ID: 35935934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
    Song H; Zhu J; Lu D
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study.
    Dilaghi E; Dottori L; Pivetta G; Dalla Bella M; Esposito G; Ligato I; Pilozzi E; Annibale B; Lahner E
    Am J Gastroenterol; 2023 Dec; 118(12):2157-2165. PubMed ID: 37207305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
    Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
    Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
    Trinh VQ; Shi C; Ma C
    Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
    Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
    Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
    PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chronic atrophic gastritis of the body-fundus and achlorhydria in the development of epithelial dysplasia and gastric carcinoma.
    Testino G; De Iaco F; Cornaggia M
    Acta Gastroenterol Belg; 2004; 67(4):327-30. PubMed ID: 15727076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis.
    Li Z; Wu C; Li L; Wang Z; Xie H; He X; Feng J
    Saudi J Gastroenterol; 2017; 23(4):222-228. PubMed ID: 28721975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
    Kapadia CR
    J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience.
    Miceli E; Vanoli A; Lenti MV; Klersy C; Di Stefano M; Luinetti O; Caccia Dominioni C; Pisati M; Staiani M; Gentile A; Capuano F; Arpa G; Paulli M; Corazza GR; Di Sabatino A
    Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1172-1180. PubMed ID: 31621927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
    Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
    Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
    Ogutmen Koc D; Bektas S
    Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
    Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
    Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
    Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
    Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk.
    Testoni PA; Masci E; Marchi R; Guslandi M; Ronchi G; Tittobello A
    J Clin Gastroenterol; 1987 Jun; 9(3):298-302. PubMed ID: 3611683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.